Vanguard Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $196M | Buy |
|
|||||
|
2025
Q1 | $202M | Buy |
|
|||||
|
2024
Q4 | $222M | Buy |
|
|||||
|
2024
Q3 | $191M | Sell |
|
|||||
|
2024
Q2 | $164M | Sell |
|
|||||
|
2024
Q1 | $212M | Sell |
|
|||||
|
2023
Q4 | $180M | Buy |
|
|||||
|
2023
Q3 | $167M | Buy |
|
|||||
|
2023
Q2 | $182M | Buy |
|
|||||
|
2023
Q1 | $213M | Buy |
|
|||||
|
2022
Q4 | $207M | Buy |
|
|||||
|
2022
Q3 | $192M | Buy |
|
|||||
|
2022
Q2 | $163M | Buy |
|
|||||
|
2022
Q1 | $179M | Buy |
|
|||||
|
2021
Q4 | $161M | Buy |
|
|||||
|
2021
Q3 | $146M | Sell |
|
|||||
|
2021
Q2 | $169M | Buy |
|
|||||
|
2021
Q1 | $143M | Buy |
|
|||||
|
2020
Q4 | $133M | Buy |
|
|||||
|
2020
Q3 | $109M | Sell |
|
|||||
|
2020
Q2 | $129M | Sell |
|
|||||
|
2020
Q1 | $98.3M | Buy |
|
|||||
|
2019
Q4 | $126M | Sell |
|
|||||
|
2019
Q3 | $148M | Buy |
|
|||||
|
2019
Q2 | $177M | Buy |
|
|||||
|
2019
Q1 | $186M | Buy |
|
|||||
|
2018
Q4 | $174M | Buy |
|
|||||
|
2018
Q3 | $258M | Buy |
|
|||||
|
2018
Q2 | $297M | Buy |
|
|||||
|
2018
Q1 | $219M | Buy |
|
|||||
|
2017
Q4 | $183M | Buy |
|
|||||
|
2017
Q3 | $180M | Buy |
|
|||||
|
2017
Q2 | $151M | Buy |
|
|||||
|
2017
Q1 | $78.8M | Buy |
|
|||||
|
2016
Q4 | $59.6M | Buy |
|
|||||
|
2016
Q3 | $54.5M | Buy |
|
|||||
|
2016
Q2 | $39.9M | Buy |
|
|||||
|
2016
Q1 | $27.1M | Buy |
|
|||||
|
2015
Q4 | $23.1M | Buy |
|
|||||
|
2015
Q3 | $20M | Buy |
|
|||||
|
2015
Q2 | $22.2M | Buy |
|
|||||
|
2015
Q1 | $10.7M | Buy |
|
|||||
|
2014
Q4 | $6.82M | Buy |
|
|||||
|
2014
Q3 | $6.72M | Buy |
|
|||||
|
2014
Q2 | $7.2M | Buy |
|
|||||
|
2014
Q1 | $4.72M | Buy |
|
|||||
|
2013
Q4 | $3.05M | Buy |
|
|||||
|
2013
Q3 | $2.61M | Buy |
|
|||||
|
2013
Q2 | $2.27M | Buy |
|